EBOS Group Ltd
ASX:EBO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
28.96
35.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EBO stock under the Base Case scenario is 50.66 AUD. Compared to the current market price of 34.2 AUD, EBOS Group Ltd is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
EBOS Group Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EBO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
EBOS Group Ltd
Balance Sheet Decomposition
EBOS Group Ltd
Current Assets | 3B |
Cash & Short-Term Investments | 216.9m |
Receivables | 1.5B |
Other Current Assets | 1.3B |
Non-Current Assets | 3.8B |
Long-Term Investments | 89.4m |
PP&E | 834.4m |
Intangibles | 2.6B |
Other Non-Current Assets | 240.5m |
Current Liabilities | 3.1B |
Accounts Payable | 2.2B |
Accrued Liabilities | 81.8m |
Other Current Liabilities | 830m |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 820m |
Other Non-Current Liabilities | 348.6m |
Earnings Waterfall
EBOS Group Ltd
Revenue
|
13.2B
AUD
|
Cost of Revenue
|
-11.6B
AUD
|
Gross Profit
|
1.6B
AUD
|
Operating Expenses
|
-1.2B
AUD
|
Operating Income
|
482.5m
AUD
|
Other Expenses
|
-211m
AUD
|
Net Income
|
271.5m
AUD
|
Free Cash Flow Analysis
EBOS Group Ltd
AUD | |
Free Cash Flow | AUD |
EBO Profitability Score
Profitability Due Diligence
EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
EBOS Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
EBO Solvency Score
Solvency Due Diligence
EBOS Group Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
EBOS Group Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EBO Price Targets Summary
EBOS Group Ltd
According to Wall Street analysts, the average 1-year price target for EBO is 36.63 AUD with a low forecast of 33.28 AUD and a high forecast of 40.88 AUD.
Dividends
Current shareholder yield for EBO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.
Officers
The intrinsic value of one EBO stock under the Base Case scenario is 50.66 AUD.
Compared to the current market price of 34.2 AUD, EBOS Group Ltd is Undervalued by 32%.